As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.
By providing infrastructure, services, educational programs and networks in global hotspots, JLABS is the best place to start a company working in healthcare, with a specific emphasis on Johnson & Johnson’s sectors: consumer, medical device and pharmaceuticals.
Media coverage could help your company attract investors and build support among key audiences, but what’s the best way to build relationships with journalists? With the advent of social media and the rise of influencer marketing, the most effective strategies for promoting your business have rapidly changed.[VJ[1]
Drawing from decade-long experience in newsrooms across the country for Bloomberg as well as from his years advising dozens of biopharma companies, Ryan will share real-world examples of tactics that he feels can work – as well as mistakes he feels entrepreneurs often make when attempting to earn media coverage.
In this “Out of the Lab and Into the Newsroom” presentation, Ryan Flinn, now Senior Director of Communications at Audentes Therapeutics, but at the time of this recording a Communications Leader at Johnson & Johnson Innovation, will share:
· Media trends and how to impact the outcome
· Media outreach practices
· Effective strategies for promoting your start up
· Tips for designing a successful media campaign
[VJ[1] https://www.pewresearch.org/fact-tank/2019/07/23/key-takeaways-state-of-the-news-media-2018/
*Please note: This webinar will be a rebroadcast of the livestream from this event which took place April 23, 2019 in San Francisco. All registrants will a link to the recording after the webinar.
For nearly two decades, I've built a career on finding, telling and sharing stories, as a journalist, media strategist and a communications leader.
Ryan Flinn has spent the past two decades telling stories professionally, first as a journalist and then as a PR Pro. In his current role as Senior Directo of Communications at Audentes Therapeutics and previously a Communications Leader for Johnson & Johnson Innovation, he helps scientists, entrepreneurs, dealmakers and start-ups define and share their passion and projects to improve healthcare, with audiences both inside and out of the company.
Prior to joining J&J in 2016, he advised clients on media strategy at communications firm W2O Group, guiding them through acquisitions, leadership changes, rebrandings, IPOs, medical meetings, FDA approvals and product launches.
Ryan spent the first half of his career as a business journalist, having published articles in the New York Times, The Boston Globe, the San Francisco Chronicle, the Washington Post, BusinessWeek and Bloomberg, where he worked for seven years.
